These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 22806098)
1. Natural and long-lasting cellular immune responses against influenza in the M2e-immune host. Schotsaert M; Ysenbaert T; Neyt K; Ibañez LI; Bogaert P; Schepens B; Lambrecht BN; Fiers W; Saelens X Mucosal Immunol; 2013 Mar; 6(2):276-87. PubMed ID: 22806098 [TBL] [Abstract][Full Text] [Related]
2. Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e. Park KS; Seo YB; Lee JY; Im SJ; Seo SH; Song MS; Choi YK; Sung YC Vaccine; 2011 Jul; 29(33):5481-7. PubMed ID: 21664216 [TBL] [Abstract][Full Text] [Related]
3. Intranasal adenovirus-vectored vaccine for induction of long-lasting humoral immunity-mediated broad protection against influenza in mice. Kim EH; Park HJ; Han GY; Song MK; Pereboev A; Hong JS; Chang J; Byun YH; Seong BL; Nguyen HH J Virol; 2014 Sep; 88(17):9693-703. PubMed ID: 24920793 [TBL] [Abstract][Full Text] [Related]
4. Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activity. Budimir N; Huckriede A; Meijerhof T; Boon L; Gostick E; Price DA; Wilschut J; de Haan A PLoS One; 2012; 7(1):e30898. PubMed ID: 22303469 [TBL] [Abstract][Full Text] [Related]
5. Heterosubtypic cross-protection induced by whole inactivated influenza virus vaccine in mice: influence of the route of vaccine administration. Budimir N; de Haan A; Meijerhof T; Gostick E; Price DA; Huckriede A; Wilschut J Influenza Other Respir Viruses; 2013 Nov; 7(6):1202-9. PubMed ID: 24102979 [TBL] [Abstract][Full Text] [Related]
6. Protection against homo and hetero-subtypic influenza A virus by optimized M2e DNA vaccine. Yao Y; Wang H; Chen J; Shao Z; He B; Chen J; Lan J; Chen Q; Chen Z Emerg Microbes Infect; 2019; 8(1):45-54. PubMed ID: 30866759 [TBL] [Abstract][Full Text] [Related]
7. Complement C3 Plays a Key Role in Inducing Humoral and Cellular Immune Responses to Influenza Virus Strain-Specific Hemagglutinin-Based or Cross-Protective M2 Extracellular Domain-Based Vaccination. Kim YJ; Kim KH; Ko EJ; Kim MC; Lee YN; Jung YJ; Lee YT; Kwon YM; Song JM; Kang SM J Virol; 2018 Oct; 92(20):. PubMed ID: 30068650 [TBL] [Abstract][Full Text] [Related]
8. Cross protection by inactivated recombinant influenza viruses containing chimeric hemagglutinin conjugates with a conserved neuraminidase or M2 ectodomain epitope. Kim KH; Jung YJ; Lee Y; Park BR; Oh J; Lee YN; Kim MC; Jeeva S; Kang SM Virology; 2020 Nov; 550():51-60. PubMed ID: 32882637 [TBL] [Abstract][Full Text] [Related]
9. Broadly Protective CD8 Zhang H; Zheng H; Guo P; Hu L; Wang Z; Wang J; Ju Y; Meng S J Virol; 2021 May; 95(12):. PubMed ID: 33827939 [TBL] [Abstract][Full Text] [Related]
10. Sublingual immunization with M2-based vaccine induces broad protective immunity against influenza. Shim BS; Choi YK; Yun CH; Lee EG; Jeon YS; Park SM; Cheon IS; Joo DH; Cho CH; Song MS; Seo SU; Byun YH; Park HJ; Poo H; Seong BL; Kim JO; Nguyen HH; Stadler K; Kim DW; Hong KJ; Czerkinsky C; Song MK PLoS One; 2011; 6(11):e27953. PubMed ID: 22140491 [TBL] [Abstract][Full Text] [Related]
11. An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus. Zhao G; Sun S; Du L; Xiao W; Ru Z; Kou Z; Guo Y; Yu H; Jiang S; Lone Y; Zheng BJ; Zhou Y Virol J; 2010 Jul; 7():151. PubMed ID: 20624292 [TBL] [Abstract][Full Text] [Related]
12. Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategies. Schotsaert M; Ysenbaert T; Smet A; Schepens B; Vanderschaeghe D; Stegalkina S; Vogel TU; Callewaert N; Fiers W; Saelens X Sci Rep; 2016 Apr; 6():24402. PubMed ID: 27072615 [TBL] [Abstract][Full Text] [Related]
13. Double-Layered M2e-NA Protein Nanoparticle Immunization Induces Broad Cross-Protection against Different Influenza Viruses in Mice. Wang Y; Deng L; Gonzalez GX; Luthra L; Dong C; Ma Y; Zou J; Kang SM; Wang BZ Adv Healthc Mater; 2020 Jan; 9(2):e1901176. PubMed ID: 31840437 [TBL] [Abstract][Full Text] [Related]
14. Modified vaccinia virus Ankara encoding influenza virus hemagglutinin induces heterosubtypic immunity in macaques. Florek KR; Weinfurter JT; Jegaskanda S; Brewoo JN; Powell TD; Young GR; Das SC; Hatta M; Broman KW; Hungnes O; Dudman SG; Kawaoka Y; Kent SJ; Stinchcomb DT; Osorio JE; Friedrich TC J Virol; 2014 Nov; 88(22):13418-28. PubMed ID: 25210172 [TBL] [Abstract][Full Text] [Related]
15. Recombinant baculovirus vaccine containing multiple M2e and adjuvant LTB induces T cell dependent, cross-clade protection against H5N1 influenza virus in mice. Zhang J; Fan HY; Zhang Z; Zhang J; Zhang J; Huang JN; Ye Y; Liao M Vaccine; 2016 Jan; 34(5):622-629. PubMed ID: 26724200 [TBL] [Abstract][Full Text] [Related]
17. Protective efficacy of a broadly cross-reactive swine influenza DNA vaccine encoding M2e, cytotoxic T lymphocyte epitope and consensus H3 hemagglutinin. Wang B; Yu H; Yang FR; Huang M; Ma JH; Tong GZ Virol J; 2012 Jun; 9():127. PubMed ID: 22738661 [TBL] [Abstract][Full Text] [Related]
18. An M2e-based synthetic peptide vaccine for influenza A virus confers heterosubtypic protection from lethal virus challenge. Ma JH; Yang FR; Yu H; Zhou YJ; Li GX; Huang M; Wen F; Tong G Virol J; 2013 Jul; 10():227. PubMed ID: 23834899 [TBL] [Abstract][Full Text] [Related]
19. UV-Inactivated rVSV-M2e-Based Influenza Vaccine Protected against the H1N1 Influenza Challenge. Olukitibi TA; Ao Z; Azizi H; Ouyang MJ; Omole T; McKinnon L; Kobasa D; Coombs K; Kobinger G; Yao X Front Biosci (Landmark Ed); 2024 May; 29(5):195. PubMed ID: 38812326 [TBL] [Abstract][Full Text] [Related]
20. Enhancing the cross protective efficacy of live attenuated influenza virus vaccine by supplemented vaccination with M2 ectodomain virus-like particles. Lee YT; Kim KH; Ko EJ; Kim MC; Lee YN; Hwang HS; Lee Y; Jung YJ; Kim YJ; Santos J; Perez DR; Kang SM Virology; 2019 Mar; 529():111-121. PubMed ID: 30685658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]